Finoriq research workspace
Bicara Therapeutics Inc. (BCAX) SEC Filings & Filing Highlights
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development. Review BCAX SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
- Company
- Bicara Therapeutics Inc. (BCAX)
- Ticker
- BCAX
- Market Cap
- $1.8B
- Latest Price
- $27.27
- Industry
- Biotech & Pharma
Bicara Therapeutics Inc. (BCAX) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Bicara Therapeutics Inc. (BCAX).
| Event | Form | Date |
|---|---|---|
| On June 9, 2026, Bicara Therapeutics Inc. held its 2026 annual meeting of stockholders. The sto...On June 9, 2026, Bicara Therapeutics Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). The stockhol... | 8-K5.07 | 2026-06-10 |
| Bicara Therapeutics Inc.: Corporate updateOn May 21, 2026, Bicara Therapeutics Inc. issued a press release entitled “Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated T... | 8-K8.01 | 2026-05-21 |
| Bicara Therapeutics Inc.: Earnings or resultsOn May 11, 2026, Bicara Therapeutics Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended Mar... | 8-K2.02 | 2026-05-11 |
| Bicara Therapeutics Inc.: Earnings or resultsOn March 30, 2026, Bicara Therapeutics Inc. (the “Company”) issued a press release announcing its financial results and business highlights... | 8-K2.02 | 2026-03-30 |
| Bicara Therapeutics Inc.: Earnings or resultsOn February 24, 2026, the Company disclosed in a preliminary prospectus supplement related to the Offering that its preliminary unaudited c... | 8-K2.02 | 2026-02-26 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.